Stocksigma LogoStocksigma Logo

SMS Pharmaceuticals Q2 FY27 Results and Key Leadership Changes

SMS Pharmaceuticals reported a 30.38% YoY increase in consolidated revenue from operations to ₹31,608.93 lakhs for the quarter ended 30th Sep'26, compared

SMS Pharmaceuticals Q2 FY27 Results and Key Leadership Changes

SMS Pharmaceuticals Ltd · Change in Management · 04 Nov 2026, 7:01 pm

SMS Pharmaceuticals Q2 FY27 Results and Key Leadership Changes SMS Pharmaceuticals reported a 30.38% YoY increase in consolidated revenue from operations to ₹31,608.93 lakhs for the quarter ended 30th Sep'26, compared to ₹24,242.95 lakhs in the previous year. Consolidated net profit rose 57.44% YoY to ₹3,985.25 lakhs from ₹2,531.27 lakhs, with basic EPS rising to ₹4.26 from ₹2.84. Separately, the Board approved the resignation of Company Secretary Thirumalesh Tumma, effective 4th Nov'26, and appointed Manohar Mollama as Company Secretary and Compliance Officer effective 5th Nov'26.

Original exchange filing (PDF)

More announcements from SMS Pharmaceuticals Ltd

All SMS Pharmaceuticals Ltd announcements